Cantargia: Rights Issue and Loan - Redeye
Bildkälla: Stockfoto

Cantargia: Rights Issue and Loan - Redeye

Redeye comments on Cantargia’s rights issue of SEK124m and loan of SEK75m, which will fund clinical programmes with nadunolimab in PDAC and MDS/AML.

Redeye comments on Cantargia’s rights issue of SEK124m and loan of SEK75m, which will fund clinical programmes with nadunolimab in PDAC and MDS/AML.
Börsvärldens nyhetsbrev